| 1 |
Bereswill S, Mousavi S, Weschka D, Buczkowski A, Schmidt S, Heimesaat MM. Iron Deprivation by Oral Deferoxamine Application Alleviates Acute Campylobacteriosis in a Clinical Murine Campylobacter jejuni Infection Model. Biomolecules 2022;13. [PMID: 36671455 DOI: 10.3390/biom13010071] [Reference Citation Analysis]
|
| 2 |
Lou H, Li X, Sheng X, Fang S, Wan S, Sun A, Chen H. Development of a Trivalent Construct Omp18/AhpC/FlgH Multi Epitope Peptide Vaccine Against Campylobacter jejuni. Front Microbiol 2021;12:773697. [PMID: 35095793 DOI: 10.3389/fmicb.2021.773697] [Reference Citation Analysis]
|
| 3 |
Karpiesiuk A, Palus K. Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in Physiological and Pathological Processes within the Gastrointestinal Tract: A Review. Int J Mol Sci 2021;22:8682. [PMID: 34445388 DOI: 10.3390/ijms22168682] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 4 |
Bereswill S, Mousavi S, Weschka D, Heimesaat MM. Disease-Alleviating Effects of Peroral Activated Charcoal Treatment in Acute Murine Campylobacteriosis. Microorganisms 2021;9:1424. [PMID: 34209438 DOI: 10.3390/microorganisms9071424] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 5 |
Mousavi S, Weschka D, Bereswill S, Heimesaat MM. Immune-Modulatory Effects upon Oral Application of Cumin-Essential-Oil to Mice Suffering from Acute Campylobacteriosis. Pathogens 2021;10:818. [PMID: 34209990 DOI: 10.3390/pathogens10070818] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Heimesaat MM, Weschka D, Mousavi S, Bereswill S. Treatment with the Probiotic Product Aviguard® Alleviates Inflammatory Responses during Campylobacter jejuni-Induced Acute Enterocolitis in Mice. Int J Mol Sci 2021;22:6683. [PMID: 34206478 DOI: 10.3390/ijms22136683] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Bereswill S, Mousavi S, Weschka D, Buczkowski A, Schmidt S, Heimesaat MM. Peroral Clove Essential Oil Treatment Ameliorates Acute Campylobacteriosis-Results from a Preclinical Murine Intervention Study. Microorganisms 2021;9:735. [PMID: 33807493 DOI: 10.3390/microorganisms9040735] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 8 |
Heimesaat MM, Mousavi S, Weschka D, Bereswill S. Anti-Pathogenic and Immune-Modulatory Effects of Peroral Treatment with Cardamom Essential Oil in Acute Murine Campylobacteriosis. Microorganisms 2021;9:169. [PMID: 33466708 DOI: 10.3390/microorganisms9010169] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 9 |
Mousavi S, Weschka D, Bereswill S, Heimesaat MM. Preclinical Evaluation of Oral Urolithin-A for the Treatment of Acute Campylobacteriosis in Campylobacter jejuni Infected Microbiota-Depleted IL-10-/- Mice. Pathogens 2020;10:7. [PMID: 33374868 DOI: 10.3390/pathogens10010007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 10 |
Heimesaat MM, Mousavi S, Escher U, Lobo de Sá FD, Peh E, Schulzke JD, Kittler S, Bücker R, Bereswill S. Resveratrol Alleviates Acute Campylobacter jejuni Induced Enterocolitis in a Preclinical Murine Intervention Study. Microorganisms 2020;8:E1858. [PMID: 33255723 DOI: 10.3390/microorganisms8121858] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
